NASDAQ:ACOR
Acorda Therapeutics Stock News
$0.661
+0 (+0%)
At Close: Apr 26, 2024
WARNING: Injectable Drugs by Homeopaths May Contain Lead and Mercury
03:27am, Thursday, 18'th Jun 2020
The FDA has identified four manufacturers labeled as homeopaths that are distributing dangerous injectable drugs.
FDA Sued For Inaction Protecting African Americans' Lives - ValueWalk
04:58pm, Wednesday, 17'th Jun 2020
Our mission is to save the 45,000 African Americans lives lost each year from tobacco-induced diseases and we have resolutely
New York, New York--(Newsfile Corp. - June 16, 2020) - Levi & Korsinsky has commenced an investigation of Acorda Therapeutics, Inc. (NASDAQ: ACOR) concerning possible breaches of fiduciary duty. To ob
Brazil’s Treasury Secretary departure rattles country’s economic team | Texto em inglês com áudio
06:18pm, Tuesday, 16'th Jun 2020
June 16th, 2020. Good evening. Brazilian National Treasury secretary, Mansueto Almeida, has decided to resign from government within the next few weeks. Almeida, who had occupied the position sinc
NEW YORK, NY / ACCESSWIRE / June 16, 2020 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary d
FDA revokes authorisation for Trump-approved malaria drug
01:25am, Tuesday, 16'th Jun 2020
The United States Food and Drug Administration will revoke its emergency authorisation of anti-malaria drug hydroxychloroquine after finding it ineffective in treating COVID-19. The FDA said "in light
FDA Withdraws Emergency Use Authorization For Hydroxychloroquine
12:00am, Tuesday, 16'th Jun 2020
The United States Food and Drug Administration on Monday withdrew the emergency use authorization it granted for hydroxychloroquine and chloroquine sulfates against the COVID-19...
'It may not be effective for COVID-19' - FDA withdraws approval for chloroquine - TheCable
06:30pm, Monday, 15'th Jun 2020
The United States Foo stration (FDA) says it is withdrawing its approval for the emergency use of two anti-malaria drugs the treatment of COVID-19
Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA region
01:34pm, Monday, 15'th Jun 2020
Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA markets and Sun Pharma will be responsible for product suppl
Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA region
09:41am, Monday, 15'th Jun 2020
Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA markets and Sun Pharma will be responsible for product suppl
Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D.
12:00am, Monday, 15'th Jun 2020
Abiomed (Nasdaq: ABMD), maker of the Impella heart pump, announced today it has appointed Charles (Chuck) Simonton, M.D., as vice president and chief
CBA appoints Simon Moutter to board: Aus shares to open higher
11:14pm, Sunday, 14'th Jun 2020
15 Jun 2020 - The Australian share market is set to open higher this morning after Wall Street rebounded on Friday. Technology and financial stocks led the recovery. Coronavirus developments will be f
Grupo ignora decreto e protesta a favor de Bolsonaro na Esplanada
03:56pm, Sunday, 14'th Jun 2020
Em v
Revised Covid treatment protocol includes remdesivir, lists loss of smell as symptom of disease
12:42am, Sunday, 14'th Jun 2020
Apex health bodies across the world, including the Centers for Disease Control and Prevention, have in the last couple of months included loss of smell among the list of COVID symptoms.
Remdesivir rollout to take more time as pharma firms working on providing safety, quality data
05:24pm, Saturday, 13'th Jun 2020
India's drug regulator had on June 1 granted US pharma giant Gilead Sciences marketing authorisation for its drug remdesivir, being touted as a potential treatment for COVID-19, in the country.
